Abstract
While for most cancers incidence and mortality are decreasing, those of non-Hodgkin’s lymphoma (NHL) are steadily increasing. Research to define reasons for this increase is extensive, but has not yet resolved them. We have conducted a literature analysis on trends regarding changes in the incidence, geographic distribution, and etiologic factors of NHL. From our own and previous analyses, an increasing NHL incidence at a rate of 3–4% per year was observed for the 1970s and 1980s. This stabilized in the 1990s, nevertheless still with an annual rise of 1–2%, resulting in almost a doubling of the NHL incidence. This rise has been noted worldwide, particularly in elderly persons >55 years. Concerning gender subgroups, a male predominance throughout all age groups is apparent. Although the NHL incidence has historically been higher in whites than blacks, disproportional increases have recently been observed in the latter group. Increases in high-grade NHL and extranodal disease are predominant. Differences in geographic distribution are striking for follicular lymphoma, which is more common in Western countries than elsewhere. Asians have higher rates of aggressive NHL, T-cell lymphomas, and extranodal disease. In the Middle East, high rates of intestinal extranodal disease are observed, whereas in Africa, endemic Burkitt’s lymphoma accounts for a substantial proportion. Risks for developing NHL include immunosuppression and a causal link between infectious agents, and lymphomagenesis has also been determined, particularly for human T-cell leukemia/lymphoma virus type 1 (HTLV-1), Epstein-Barr virus (EBV), and Helicobacter pylori infections. Exposure to environmental agents and occupational risks have been studied; however, their significance is as yet uncertain.
Similar content being viewed by others
References
Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B, Ekbom A, Adami HO, Granath F (2003) Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 89:1221–1227
Altekruse SF, Henley SJ, Thun MJ (1999) Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control 10:617–625
Anderson JR, Armitage JO, Weisenburger DD (1998) Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s lymphoma classification project. Ann Oncol 9:717–720
Arisawa K, Soda M, Endo S, Kurokawa K, Katamine S, Shimokawa I, Koba T, Takahashi T, Saito H, Doi H, Shirahama S (2000) Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 85:319–324
Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM, Dalla-Favera R (1993) Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma. Blood 81:166–176
Banks PM (1992) Changes in diagnosis of non-Hodgkin’s lymphomas over time. Cancer Res 52:5453s–5455s
Bentham G (1996) Association between incidence of non-Hodgkin’s lymphoma and solar ultraviolet radiation in England and Wales. BMJ 312:1128–1131
Boice JD Jr (1992) Radiation and non-Hodgkin’s lymphoma. Cancer Res 52:5489s–5491s
Cancer facts and figures 2004. American Cancer Society (www.cancer.org)
Cantor KP, Blair A, Everett G, VanLier S, Burmeister L, Dick FR, Gibson RW, Schuman L (1988) Hair dye use and risk of leukemia and lymphoma. Am J Public Health 78:570–571
Carli PM, Boutron MC, Maynadie M, Bailly F, Caillot D, Petrella T (1994) Increase in the incidence of non-Hodgkin’s lymphomas: evidence for a recent sharp increase in France independent of AIDS. Br J Cancer 70:713–715
Cartwright RA (1992) Changes in the descriptive epidemiology of non-Hodgkin’s lymphoma in Great Britain? Cancer Res 52:5441s–5442s
Casanova M, Cole P, Collins JJ, Conolly R, Delzell E, Heck Hd HA, Leonard R, Lewis R, Marsh GM, Ott MG, Sorahan T, Axten CW (2004) Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J Natl Cancer Inst 96:966–967
Cerhan JR, Wallace RB, Folsom AR, Potter JD, Sellers TA, Zheng W, Lutz CT (1997) Medical history risk factors for non-Hodgkin’s lymphoma in older women. J Natl Cancer Inst 89:314–318
Cerhan JR, Janney CA, Vachon CM, Habermann TM, Kay NE, Potter JD, Sellers TA, Folsom AR (2002) Anthropometric characteristics, physical activity, and risk of non-Hodgkin’s lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 156:527–535
Clarke CA (2001) Changing incidence of Kaposi’s sarcoma and non-Hodgkin’s lymphoma among young men in San Francisco. AIDS 15:1913–1915
Clarke CA, Glaser SL (2002) Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 94:2015–2023
Collins JJ, Ireland B, Buckley CF, Shepperly D (2003) Lymphohaematopoeitic cancer mortality among workers with benzene exposure. Occup Environ Med 60:676–679
Cook-Mozaffari P, Newton R, Beral V, Burkitt DP (1998) The geographical distribution of Kaposi’s sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 78:1521–1528
Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, Sategna Guidetti C, Usai P, Cesari P, Pelli MA, Loperfido S, Volta U, Calabro A, Certo M, Club del Tenue Study Group (2001) Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 358:356–361
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867
Dal Maso L, Serraino D, Franceschi S (2001) Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer 37:1188–1201
Dalton SO, Johansen C, Mellemkjaer L, Sorensen HT, McLaughlin JK, Olsen J, Olsen JH (2000) Antidepressant medications and risk for cancer. Epidemiology 11:171–176
Devesa SS, Fears T (1992) Non-Hodgkin’s lymphoma time trends: United States and international data. Cancer Res 52:5432s–5440s
De Vita S, Sacco C, Sansonno D, Gloghini A, Dammacco F, Crovatto M, Santini G, Dolcetti R, Boiocchi M, Carbone A, Zagonel V (1997) Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 90:776–782
Dong C, Hemminki K (2001) Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958–1996: a search for common mechanisms. Br J Cancer 85:997–1005
Echimane AK, Ahnoux AA, Adoubi I, Hien S, M’Bra K, D’Horpock A, Diomande M, Anongba D, Mensah-Adoh I, Parkin DM (2000) Cancer incidence in Abidjan, Ivory Coast: first results from the cancer registry, 1995–1997. Cancer 89:653–663
Ferlay J, Bray F, Pisani P, Parkin DM (2001) Globocan 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC CancerBase No. 5. IARC, Lyon. Limited version available from http://www-dep.iarc.fr/globocan/globocan.htm (last updated on 03/02/2001)
Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell’Oro S, Fleischhauer K, Caggiari L, Lettini AA, Dal Cin E, Ieri R, Freschi M, Villa E, Boiocchi M, Dolcetti R (2004) Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 96:586–594
Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A (1994) Hepatitis C virus infection in patients with non-Hodgkin’s lymphoma. Br J Haematol 88:392–394
Filipovich AH, Mathur A, Kamat D, Shapiro RS (1992) Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 52:5465s–5467s
Franchini G, Fukumoto R, Fullen JR (2003) T-cell control by human T-cell leukemia/lymphoma virus type 1. Int J Hematol 78:280–296
Freedman DM, Zahm SH, Dosemeci M (1997) Residential and occupational exposure to sunlight and mortality from non-Hodgkin’s lymphoma: composite (threefold) case-control study. BMJ 314:1451–1455
Gisbert JP, Khorrami S, Calvet X, Pajares JM (2004) Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 16:89–99
Gniadecki R, Rossen K, Ralfkier E, Thomsen K, Skovgaard GL, Jonsson V (2004) CD56+ lymphoma with skin involvement: clinicopathologic features and classification. Arch Dermatol 140:427–436
Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI (2003) Risk of malignancy in patients with celiac disease. Am J Med 115:191–195
Greiner TC, Medeiros LJ, Jaffe ES (1995) Non-Hodgkin’s lymphoma. Cancer 75:370–380
Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R, Fraumeni JF Jr (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85:307–311
Groves FD, Linet MS, Travis LB, Devesa SS (2000) Cancer surveillance series: non-Hodgkin’s lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 92:1240–1251
Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM (2000) B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin’s lymphoma in people with AIDS. AIDS 14:133–140
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC (1994) A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol 17:3835–3849
Hartge P, Devesa SS, Fraumeni JF Jr (1994) Hodgkin’s and non-Hodgkin’s lymphomas. Cancer Surv 19–20:423–453
Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF Jr (1996) Non-Hodgkin’s lymphoma and sunlight. J Natl Cancer Inst 88:298–300
Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A (2003) Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J Natl Cancer Inst 95:1615–1623
Hemminki K, Li X, Czene K (2004) Familial risk of cancer: data for clinical counseling and cancer genetics. Int J Cancer 108:109–114
Herrinton LJ, Friedman GD (1998) Cigarette smoking and risk of non-Hodgkin’s lymphoma subtypes. Cancer Epidemiol Biomarkers Prev 1:25–28
Herrinton LJ, Goldoft M, Schwartz SM, Weiss NS (1996) The incidence of non-Hodgkin’s lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants. Cancer Causes Control 7:224–230
Hoover RN (1992) Lymphoma risks in populations with altered immunity—a search for mechanism. Cancer Res 52:5477s–5478s
Hu S, Ma F, Collado-Mesa F, Kirsner RS (2004) Ultraviolet radiation and incidence of non-Hodgkin’s lymphoma among Hispanics in the United States. Cancer Epidemiol Biomarkers Prev 13:59–64
Intragumtornchai T, Wannakrairoj P, Chaimongkol B, Bhoopat L, Lekhakula A, Thamprasit T, Suwanwela N, Suthipinthawong C, Prayoonwiwat W, Meekungwal P, Sirijerachai C, Pairojkul C (1996) Non-Hodgkin’s lymphomas in Thailand. A retrospective pathologic and clinical analysis of 1391 cases. Cancer 78:1813–1819
Kadan-Lottick NS, Skluzacek MC, Gurney JG (2002) Decreasing incidence rates of primary central nervous system lymphoma. Cancer 95:193–202
Kato I, Koenig KL, Baptiste MS, Lillquist PP, Frizzera G, Burke JS, Watanabe H, Shore RE (2003) History of antibiotic use and risk of non-Hodgkin’s lymphoma (NHL). Int J Cancer 107:99–105
Kuppers R (2003) B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 3:801–812
Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, Bengoufa D, Feuillard J, Lavergne A, Gordon JI, Berche P, Guillevin L, Lortholary O (2004) Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 350:239–248
Levine AM, Shibata D, Sullivan-Halley J, Nathwani B, Brynes R, Slovak ML, Mahterian S, Riley CL, Weiss L, Levine PH et al (1992) Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma in the county of Los Angeles: preliminary results. Cancer Res 52:5482s–5484s
Linet MS, Pottern LM (1992) Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin’s lymphoma. Cancer Res 52:5468s–5473s
Little RF, Pittaluga S, Grant N, Steinberg SM, Kavlick MF, Mitsuya H, Franchini G, Gutierrez M, Raffeld M, Jaffe ES, Shearer G, Yarchoan R, Wilson WH (2003) Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 101:4653–4659
Lymphoma Study Group of Japanese Pathologists (2000) The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 50:696–702
Maartense E, Kluin-Nelemans HC, Noordijk EM (2003) Non-Hodgkin’s lymphoma in the elderly. A review with emphasis on elderly patients, geriatric assessment, and future perspectives. Ann Hematol 82:661–670
Mariette X (2001) Lymphomas complicating Sjogren’s syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis 60:1007–1010
McKean-Cowdin R, Feigelson HS, Ross RK, Pike MC, Henderson BE (2000) Declining cancer rates in the 1990s. J Clin Oncol 18:2258–2268
McKenna DB, Stockton D, Brewster DH, Doherty VR (2003) Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 88:74–78
Morton LM, Engels EA, Holford TR, Leaderer B, Zhang Y, Zahm SH, Boyle P, Zhang B, Flynn S, Tallini G, Owens PH, Zheng T (2004) Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women. Cancer Epidemiol Biomarkers Prev 13:425–430
Nakhleh RE, Manivel JC, Copenhaver CM, Sung JH, Strickler JG (1991) In situ hybridization for the detection of Epstein-Barr virus in central nervous system lymphomas. Cancer 67:444–448
Nelson RA, Levine AM, Marks G, Bernstein L (1997) Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin’s lymphoma. Br J Cancer 76:1532–1537
Nelson RA, Levine AM, Bernstein L (2001) Reproductive factors and risk of intermediate- or high-grade B-cell non-Hodgkin’s lymphoma in women. J Clin Oncol 19:1381–1387
Newton R, Roman E, Fear N, Carpenter L (1996) Non-Hodgkin’s lymphoma and solar ultraviolet radiation. Data are inconsistent. BMJ 313:298
Newton R, Ferlay J, Beral V, Devesa SS (1997) The epidemiology of non-Hodgkin’s lymphoma: comparison of nodal and extra-nodal sites. Int J Cancer 72:923–930
Olson JE, Janney CA, Rao RD, Cerhan JR, Kurtin PJ, Schiff D, Kaplan RS, O’Neill BP (2002) The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 95:1504–1510
Palackdharry CS (1994) The epidemiology of non-Hodgkin’s lymphoma: why the increased incidence? Oncology 8:67–73
Parkin DM, Garcia-Giannoli H, Raphael M, Martin A, Katangole-Mbidde E, Wabinga H, Ziegler J (2000) Non-Hodgkin lymphoma in Uganda: a case-control study. AIDS 14:2929–2936
Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267–1271
Pearce N, Bethwaite P (1992) Increasing incidence of non-Hodgkin’s lymphoma: occupational and environmental factors. Cancer Res 52:5496s–5500s
Persing DH, Prendergast FG (1999) Infection, immunity, and cancer. Arch Pathol Lab Med 123:1015–1022
Rabkin CS, Tess BH, Christianson RE, Wright WE, Waters DJ, Alter HJ, Van Den Berg BJ (2002) Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 99:4240–4242
Ramos-Casals M, Trejo O, Garcia-Carrasco M, Cervera R, De La Red G, Gil V, Lopez-Guillermo A, Ingelmo M, Font J (2004) Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma. J Rheumatol 31:495–499
Rossi G, Donisi A, Casari S, Re A, Cadeo G, Carosi G (1999) The international prognostic index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma. Cancer 86:2391–2397
Sasieni P, Bataille V (1995) Non-Hodgkin’s lymphoma and skin cancer. Ultraviolet light is unlikely explanation for association. BMJ 311:749
Scherr PA, Hutchison GB, Neiman RS (1992) Non-Hodgkin’s lymphoma and occupational exposure. Cancer Res 52:5503s–5509s
Schroeder JC, Olshan AF, Baric R, Dent GA, Weinberg CR, Yount B, Cerhan JR, Lynch CF, Schuman LM, Tolbert PE, Rothman N, Cantor KP, Blair A (2002) A case-control study of tobacco use and other non-occupational risk factors for t(14;18) subtypes of non-Hodgkin’s lymphoma (United States). Cancer Causes Control 2:159–168
Shih LY, Liang DC (1991) Non-Hodgkin’s lymphomas in Asia. Hematol Oncol Clin North Am 5:983–1001
Sorensen HT, Mellemkjaer L, Nielsen GL, Baron JA, Olsen JH, Karagas MR (2004) Skin cancers and non-Hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Inst 96:709–711
Sukpanichnant S, Sonakul D, Piankijagum A, Wanachiwanawin W, Veerakul G, Mahasandana C, Tanphaichitr VS, Suvatte V (1998) Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital. Cancer 83:1197–1204
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence—SEER 9 Regs. Public-Use, Nov 2002 Sub (1973–2000). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003
Ward MH, Zahm SH, Weisenburger DD, Gridley G, Cantor KP, Saal RC, Blair A (1994) Dietary factors and non-Hodgkin’s lymphoma in Nebraska (United States). Cancer Causes Control 5:422–432
Weisenburger DD (1994) Epidemiology of non-Hodgkin’s lymphoma: recent findings regarding an emerging epidemic. Ann Oncol 5:19–24
Westin EH, Longo DL (2004) Lymphoma and myeloma in older patients. Semin Oncol 31:198–205
Willemze R (2003) Cutaneous T-cell lymphoma: epidemiology, etiology, and classification. Leuk Lymphoma 44:S49–S54
Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LA, Anderson RN, Thun MJ (2003) Long-term trends in cancer mortality in the United States, 1930–1998. Cancer 97:3133–3275
Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50:1740–1751
Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, Adam HO (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12:13–21
Wotherspoon AC (1998) Helicobacter pylori infection and gastric lymphoma. Br Med Bull 54:79–85
Zahm SH, Blair A (1992) Pesticides and non-Hodgkin’s lymphoma. Cancer Res 52:5485s–5488s
Zahm SH, Weisenburger DD, Babbitt PA, Saal RC, Vaught JB, Blair A (1992) Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Am J Public Health 82:990–997
Zahm SH, Weisenburger DD, Holmes FF, Cantor KP, Blair A (1997) Tobacco and non-Hodgkin’s lymphoma: combined analysis of three case-control studies (United States). Cancer Causes Control 2:159–166
Zhang SM, Hunter DJ, Rosner BA, Giovannucci EL, Colditz GA, Speizer FE, Willett WC (2000) Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin’s lymphoma among women. Cancer Epidemiol Biomarkers Prev 9:477–485
Zhang Y, Holford TR, Leaderer B, Boyle P, Zahm SH, Flynn S, Tallini G, Owens PH, Zheng T (2004) Hair-coloring product use and risk of non-Hodgkin’s lymphoma: a population-based case-control study in Connecticut. Am J Epidemiol 159:148–154
Zhao X, Sun NC, Witt MD, Keller M, Niihara Y (2004) Changing pattern of AIDS: a bone marrow study. Am J Clin Pathol 121:393–401
Acknowledgments
With special thanks to Teresa Leigh for proofreading this paper. We also thank the internal reviewer in our institution, Prof. Dr. H. Veelken, as well as the anonymous external reviewer for critical reading of the manuscript and valuable suggestions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Müller, A.M.S., Ihorst, G., Mertelsmann, R. et al. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84, 1–12 (2005). https://doi.org/10.1007/s00277-004-0939-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-004-0939-7